Strategic network in key regions – Europe, Japan, India, China
OTIF performance (On-Time shipments In Full shipments): 92-95% in 2025
We are member of Pharmaceutical Supply Chain Initiative (PSCI)
Global Supply Chain Network
Supply Chain Solutions for Global Reach and On-Time Delivery
At AGC Pharma Chemicals, our supply chain is designed to provide flexibility, stability, and on-time delivery across global markets. With a strategic network in key regions —Europe, Japan, India, and China— we offer a seamless, end-to-end supply chain solution that minimizes risks and ensures continuous delivery.
Our main site in Barcelona plays a critical role in maintaining a stable supply chain while providing a global reach with a local presence. Through strategic partnerships, we ensure cost-competitive and robust processes, from scale-up through commercial drug substance manufacturing.
OTIF & On-Time Delivery
In 2025, we maintained an OTIF (On-Time In-Full) performance of 92–95%. This high OTIF performance reflects our ability to combine manufacturing reliability, efficient logistics and coordinated global operations.
Reliable delivery is one of the foundations of our supply chain strategy. Maintaining an OTIF performance between 99% and 100% over four consecutive years demonstrates the consistency of our manufacturing operations, planning processes and logistics network.
This performance helps customers reduce supply risks while ensuring continuity throughout commercial manufacturing.
Supplier Qualification
We conduct rigorous supplier management through three stages—selection, qualification, and evaluation—to maintain high standards of quality and reliability.
Supplier qualification follows structured assessment processes designed to ensure quality, business continuity and long-term supply reliability across our global manufacturing network.
GDP & GMP Compliance
Our raw material management is optimized to provide agility and efficiency to our production. We are aligned with the service level targets, fully compliant in GMP regulation in the warehouse, GDP in worldwide distribution and export trade requirements for worldwide distribution.
Compliance with GMP warehouse requirements and GDP distribution standards helps ensure product integrity throughout storage, handling and global distribution activities.
These processes support reliable pharmaceutical manufacturing services while maintaining regulatory compliance across international markets.
Backward Integration
Through our non-GMP facilities in Japan, we can offer backward integration in your supply chain.
Backward integration strengthens supply security by improving raw material availability and increasing manufacturing flexibility for drug substance manufacturing projects.
This additional level of integration helps reduce supply risks while supporting long-term manufacturing continuity.
Key Benefits:
- On time and stable supply: OTIF (On-Time In-Full) performance of 92–95% in 2025.
- Strategic procurement locations in Europe, Japan, India, and China.
- Seamless supply chain integration from process development to production.
- Rigorous supplier evaluation and qualification.
- Backward integration proposal.
- PSCI-compliant audit process for enhanced transparency.
- Cost-efficient, robust supply chain and manufacturing processes.
The critical role of a resilient and flexible supply chain in ensuring on-time delivery
The pharmaceutical industry has witnessed a significant shift towards building a more resilient and flexible supply chain that can adapt to the changing dynamics of the world.
CDMOs Supply Chain: capabilities and strategy
AGC Pharma Chemicals is pioneering the shift towards elevating supply chain operations to a higher level of performance through collaboration and transparency.